Skip to main content
. 2010 Sep;156(Pt 9):2660–2669. doi: 10.1099/mic.0.041202-0

Table 2.

Plasmid constructs

Plasmid Primer or fragment used* Construction†
pLJH1 (rsbT1) T-1 5′ TGCGGATCCATTCCAGGAAGATTTGC 3′ pKSV7 BamHI–PstI
T-2 5′ GGACCTTTGTTTTTGGCAAC 3′
T-3 5′ GTTGCCAAAAACAAAGGTCC 3′
T-4 5′ TTCCTGCAGAGCAATTTCACTACGTA 3′
pLJH2 (rsbUΔ1) U-1 5′ CTCGGATCCACGTTTAGCGGAGTAC 3′ pKSV7 BamHI–PstI
U-2 5′ CACTTCTTCTTATTTAGTTTTTTCCATTTTTTTCTAGCT 3′
U-3 5′ ACTAAATAAGAAGAAGTGAAG 3′
U-4 5′ AGGCTGCAGAGGAAGTTGTAATGTAA 3′
pLJH3 F 5′ CTTCCTGCAGAATGTAACACTGTCTTT 3′ pPL2 PstI–BamHI
R 5′ TTTGGATCCTTTATAAGTCTTCGTTAC 3′
pLJH4 BglII–BamHI from pHK77, encoding spoVG–lacZ fusion pLJH3 SacI–BamHI
pLJH5 (rsbRA) F 5′ GAAAGGATCCGATGTATAAAGATTTTGCA 3′ pET-15b BamHI–BlpI
R 5′ CCCGCTCAGCTCACCCCTCTTTTTCTAC 3′
pLJH6 (rsbS) F 5′ GGTGGATCCTGTGGGGATACCAATCTTA 3′ pET-15b BamHI–BlpI
R 5′ GAATGCTCAGCTCATTCCCCCAATTCCTG 3′
pLJH7 (rsbT) F 5′ GGGGGATCCCATGACATTCCAATCCTGT 3′ pET-15b BamHI–BlpI
R 5′ CTAGCTCAGCTTACCGAACCCATTTCGT 3′

*Restriction endonuclease sites used for cloning are denoted by underlined italic type.

†Vector and sites used: pKSV7 (Smith & Youngman, 1992); pPL2 (Lauer et al., 2002); pET15b (Novagen).